{"id":"https://openalex.org/W4385409041","doi":"https://doi.org/10.1021/acs.oprd.3c00172","title":"Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing","display_name":"Developing and Optimizing a Quench-Crystallization Operation in Drug Substance Manufacturing","publication_year":2023,"publication_date":"2023-07-31","ids":{"openalex":"https://openalex.org/W4385409041","doi":"https://doi.org/10.1021/acs.oprd.3c00172"},"language":"en","primary_location":{"id":"doi:10.1021/acs.oprd.3c00172","doi":"https://doi.org/10.1021/acs.oprd.3c00172","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.3c00172","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research &amp; Development","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002313071","display_name":"Daniel J. Griffin","orcid":"https://orcid.org/0000-0002-5051-2069","observed_orcids":["https://orcid.org/0000-0002-5051-2069"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel J. Griffin","raw_affiliation_strings":["Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":"https://orcid.org/0000-0002-5051-2069","affiliations":[{"raw_affiliation_string":"Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007796068","display_name":"Liang Zhang","orcid":"https://orcid.org/0000-0001-5108-1638","observed_orcids":["https://orcid.org/0000-0001-5108-1638"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Liang Zhang","raw_affiliation_strings":["Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":"https://orcid.org/0000-0001-5108-1638","affiliations":[{"raw_affiliation_string":"Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092779292","display_name":"James D. Fostinis","orcid":"https://orcid.org/0009-0008-2288-6814","observed_orcids":["https://orcid.org/0009-0008-2288-6814"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James D. Fostinis","raw_affiliation_strings":["Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":"https://orcid.org/0009-0008-2288-6814","affiliations":[{"raw_affiliation_string":"Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066345448","display_name":"Andrew T. Parsons","orcid":"https://orcid.org/0000-0002-0320-0919","observed_orcids":["https://orcid.org/0000-0002-0320-0919"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew T. Parsons","raw_affiliation_strings":["Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States"],"raw_orcid":"https://orcid.org/0000-0002-0320-0919","affiliations":[{"raw_affiliation_string":"Pivotal & Commercial Synthetics, Process Development, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002313071","https://openalex.org/A5007796068"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.2215,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.34770335,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"27","issue":"8","first_page":"1499","last_page":"1509"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10402","display_name":"Phase Equilibria and Thermodynamics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13180","display_name":"Chemistry and Chemical Engineering","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-substance-manufacturing","display_name":"drug substance manufacturing","score":0.8140000104904175},{"id":"https://openalex.org/keywords/reactive-crystallization","display_name":"reactive crystallization","score":0.7559999823570251},{"id":"https://openalex.org/keywords/process-analytical-technology","display_name":"process analytical technology","score":0.6190000176429749},{"id":"https://openalex.org/keywords/cooling-crystallization","display_name":"cooling crystallization","score":0.7540000081062317},{"id":"https://openalex.org/keywords/antisolvent-crystallization","display_name":"antisolvent crystallization","score":0.9890000224113464},{"id":"https://openalex.org/keywords/intermediate-isolation","display_name":"intermediate isolation","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C203036418","wikidata":"https://www.wikidata.org/wiki/Q284256","display_name":"Crystallization","level":2,"score":0.9303327798843384},{"id":"https://openalex.org/C177212765","wikidata":"https://www.wikidata.org/wiki/Q627335","display_name":"Workflow","level":2,"score":0.5753675699234009},{"id":"https://openalex.org/C2988729646","wikidata":"https://www.wikidata.org/wiki/Q838129","display_name":"Process development","level":2,"score":0.5301925539970398},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.5101447701454163},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.47929471731185913},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4762689769268036},{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.46791937947273254},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.45512741804122925},{"id":"https://openalex.org/C2987875673","wikidata":"https://www.wikidata.org/wiki/Q187939","display_name":"Manufacturing process","level":2,"score":0.43374699354171753},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.37147170305252075},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.33755022287368774},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.2054165005683899},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07701650261878967},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06609120965003967},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.05320730805397034},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.oprd.3c00172","doi":"https://doi.org/10.1021/acs.oprd.3c00172","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.oprd.3c00172","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research &amp; Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5199999809265137}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1967391483","https://openalex.org/W2029438461","https://openalex.org/W2030576928","https://openalex.org/W2043236696","https://openalex.org/W2088460496","https://openalex.org/W2100347683","https://openalex.org/W2168614130","https://openalex.org/W2318153819","https://openalex.org/W2936347390","https://openalex.org/W3097710712","https://openalex.org/W3129746225","https://openalex.org/W4242514032","https://openalex.org/W4252929690","https://openalex.org/W4286482534","https://openalex.org/W4306822076"],"related_works":["https://openalex.org/W1980439193","https://openalex.org/W3016264039","https://openalex.org/W2136355714","https://openalex.org/W2221524510","https://openalex.org/W1973350855","https://openalex.org/W7215360452","https://openalex.org/W226482800","https://openalex.org/W2767057000","https://openalex.org/W2333179362","https://openalex.org/W4412783840"],"abstract_inverted_index":{"We":[0],"describe":[1],"the":[2,14,17,28,36,67],"development":[3,37],"of":[4,16,27,38,69],"a":[5],"triphasic":[6],"quench-crystallization":[7,29],"operation":[8,30],"to":[9],"isolate":[10],"an":[11],"intermediate":[12],"in":[13],"manufacture":[15,59],"sotorasib":[18],"drug":[19,57],"substance.":[20],"Using":[21],"this":[22,65],"case":[23],"study,":[24],"unique":[25],"aspects":[26],"are":[31],"highlighted":[32],"and":[33,49,62],"contrasted":[34],"with":[35],"more":[39],"commonly":[40],"discussed":[41],"cooling/antisolvent":[42],"crystallization":[43,53],"operations.":[44],"A":[45],"workflow":[46],"for":[47,55],"exploring":[48],"developing":[50],"complex,":[51],"reactive":[52],"operations":[54],"commercial":[56],"substance":[58],"is":[60,75],"proposed":[61],"illustrated.":[63],"Within":[64],"framework,":[66],"utility":[68],"applying":[70],"process":[71],"analytical":[72],"technology":[73],"(PAT)":[74],"demonstrated.":[76]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2023-08-01T00:00:00"}
